India’s pharma export numbers for the first half of FY27 reach USD 16.14 billion, a 4.9% rise from USD 15.38 billion a year earlier
Autoimmune drug discovery is gaining attention as ICMR backs a four-year Indian study exploring genetic links and shared treatment targets across affected families nationally.
World markets drive Strides Pharma’s 17% rise this quarter as the company’s non-US markets generate more revenue than its traditional American business for the first time.
The London Biotechnology Show 2026 will return to ExCeL London on 18–19 November, bringing together biotechnology and pharmaceutical companies, researchers, healthcare professionals, investors, policymakers and technology providers
Philips' Oxygenate 5 launch puts home oxygen therapy access, affordability and long-term respiratory care in India under the spotlight as COPD-related healthcare needs grow nationally.
Health Ministry launches Tobacco Free Youth Campaign 4.0, targeting colleges and universities to close tobacco free gaps across Indian states.
Apollo Hospitals has launched an AI-assisted stroke care programme, raising questions about how AI stroke triage can accelerate emergency decisions and improve treatment pathways.
Fortis Suguna Hospital acquisition adds 110 beds in Bengaluru, with planned clinical upgrades and expansion offering potential for long-term growth.
TB Alliance loses patent fight in India as rejection of its six-month BPaL cure patent supports affordable drug-resistant tuberculosis treatment.
Lilly’s triple agonist retatrutide outmuscles Ozempic on weight loss, delivering greater weight reduction and blood sugar control in trials.
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
